Restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP.
Nearly 90% of human melanomas contain inactivated wild-type p53, the underlying mechanisms for which are not fully understood. Here, we identify that cyclin B1/CDK1-phosphorylates iASPP, which leads to the inhibition of iASPP dimerization, promotion of iASPP monomer nuclear entry, and exposure of it...
Main Authors: | Lu, M, Breyssens, H, Salter, V, Zhong, S, Hu, Y, Baer, C, Ratnayaka, I, Sullivan, A, Brown, N, Endicott, J, Knapp, S, Kessler, B, Middleton, MR, Siebold, C, Jones, E, Sviderskaya, E, Cebon, J, John, T, Caballero, O, Goding, C, Lu, X |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Correction: restoring p53 function in human melanoma cells by inhibiting MDM2 and cyclin B1/CDK1-phosphorylated nuclear iASPP
by: Lu, M, et al.
Published: (2016) -
Investigating the role of iASPP and ASPP2 in human carcinoma
by: Salter, V
Published: (2014) -
Nuclear iASPP may facilitate prostate cancer progression.
by: Morris, E, et al.
Published: (2014) -
Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
by: Notari, M, et al.
Published: (2011) -
iASPP in the balance between tolerance and autoimmunity
by: Akama-Garren, E
Published: (2017)